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Abstract 
 
Assembly of ERMES Subunit Mdm12 and its Interaction with Synthetic Lipid Bilayers 
 
Adrian Coscia, University Scholar Program 
 
University of Connecticut 
2017 
 
 The endoplasmic reticulum—mitochondria encounter structure (ERMES) is a tethering 
complex that mediates the close apposition of ER and mitochondrial membranes. The ERMES 
complex consists of at least four proteins: the ER transmembrane protein Mmm1, the 
mitochondrial outer membrane (OM) protein Mdm34, the OM β-barrel protein Mdm10, and the 
cytosolic protein Mdm12. Accumulating evidence suggests that the ERMES complex provides 
the molecular basis for non-vesicular phospholipid transport between the ER and mitochondria. 
Yet how these subunits assemble into a quaternary membrane tether is poorly understood, and 
the mechanism of ERMES-mediated phospholipid transport has yet to be revealed. Both of these 
aspects are necessary prerequisites for developing a thorough picture of not only lipid transport 
at ER—mitochondria contact sites, but of non-vesicular lipid transport in general. Here we show 
that full-length Mdm12 of S. cerevisiae exists primarily as a disulfide-mediated dimer in 
dynamic equilibrium. We also demonstrate novel features of Mdm12—bilayer interaction, in 
particular that Mdm12 induces fusion, lysis, solubilization, and aggregation of synthetic lipid 
bilayers. The results show that the reductant DTT and calcium both modulate the kinetics of 
Mdm12 lipid binding. Structural aspects of Mdm12 lipid-binding specificity are also addressed 
by in silico phospholipid docking. 
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Introduction 
I. The Endoplasmic Reticulum-Mitochondria Junction 
 Many processes within eukaryotic cells depend on dynamic membrane-bound organelles 
that segregate specific metabolic processes into compartmentalized microenvironments. Yet cells 
must also choreograph the transport of proteins, signaling molecules, lipids, and other 
metabolites between sets of organelles for appropriate function. Intracellular membrane contact 
sites (MCS) were first identified by electron microscopy as tightly coordinated associations 
between organelles1. In particular, specialized domains of the endoplasmic reticulum (ER), 
termed mitochondrial-associated membranes (MAMs), form zones of close (~10-50 nm) 
apposition with the mitochondrial outer membrane (OM)1-5 (Fig. 1A). These junctions play a 
number of critical roles in signaling, metabolism, and organelle dynamics that require 
coordination between the ER and mitochondria.  
 Of particular interest, lipid biogenesis requires the transport of lipids between the ER (the 
major site of lipid synthesis) and the mitochondrion (Fig. 1A, left). Mitochondria contain 
A
B
Figure 1. The ERMES Complex
A) The ER-mitochondrial junction tethered by 
ERMES (subunits: Mmm1, red; Mdm10, yellow; 
Mdm34, green; Mdm12, cyan). Phospholipid traffick-
ing routes (left) comprise transport to mitochondria 
(solid lines) and transport to the ER (dotted lines). 
Ca2+ exchange (right) occurs from the IP3R channel to 
the mitochondrial uptake machinery (VDAC/MCU).
B) ERMES subunits and domain organization. 
Subunits are depicted with relevant residues (Saccha-
romyces cerevisiae numbering). Abbreviations: 
TMS, transmembrane segment; SMP, synaptotag-
min-like, mitochondrial lipid binding protein.
(Image courtesty of Dr. Nathan Alder)
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enzymes necessary to synthesize some resident phospholipids [e.g. phosphatidic acid (PA), 
phosphatidylethanolamine (PE), phosphatidylglycerol (PG) and cardiolipin (CL)], but other 
lipids must be imported from their primary site of synthesis on the ER/MAM membrane6. For 
instance phosphatidylserine (PS) first synthesized on the ER is decarboxylated to PE in the 
mitochondrial inner membrane (IM) and trafficked back to the ER, where it can be further 
modified into phosphatidylcholine (PC)7 (Fig. 1A). PC and PE are the two most abundant 
phospholipids in many biological membranes, and consequently several organisms depend on PS 
decarboxylation in mitochondria as the major source of PE necessary for appropriate function. 
Importantly, because mitochondria are not part of the endomembrane system, this bidirectional 
lipid transport must be non-vesicular8. Clearly, this bidirectional lipid trafficking is a 
fundamental process in organellar biogenesis. 
 The second preeminent function of the ER-mitochondria contact site is interorganellar 
Ca2+ signaling (Fig. 1A, right). Mitochondrial Ca2+ uptake is critical for cellular Ca2+ 
homeostasis, the regulation of mitochondrial enzymes, and has been linked to pathologies such 
as cancer, Alzheimer’s disease, and Parkinson’s disease9-14. Upon stimulus, transmembrane IP3 
receptors (IP3R) release Ca2+ stored in the ER, forming microdomains of high calcium 
concentration (20-40 µM) in close proximity (~15 nm) to ER-mitochondria contact sites15-17. 
Ca2+ uptake at the mitochondrial OM is mediated by the non-specific voltage-dependent anion 
channel (VDAC), which is coupled to the inner membrane Ca2+ uniporter (MCU)18-20. Notably, 
because the affinity of MCU for Ca2+(20-30 µM) is lower than cytosolic Ca2+ concentration, 
these microdomains are required for MCU-mediated response16, 17, 18. It follows that distance 
plasticity between juxtaposed membranes may be important in regulating mitochondrial Ca2+ 
response5. 
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II. The ERMES Complex 
In 2009 a synthetic biology screen in Saccharomyces cerevisiae led to the identification 
of the ER-mitochondria encounter structure (ERMES), a tethering complex that mediates ER-
mitochondrial association21. The ERMES complex is localized to discrete punctae at contact sites 
and consists of at least four proteins: the ER-anchored protein Mmm1, the mitochondrial protein 
Mdm34, the OM β-barrel protein Mdm10, and the cytosolic protein Mdm12 (Fig. 1A). A 
subsequent study identified the Ca2+-binding Miro GTPase Gem1 as an integral and regulatory 
component of ERMES22. In addition to its conspicuous role as a membrane tether, initial genetic 
interaction screens and biochemical studies implicated the ERMES complex in lipid transport, 
Ca2+ exchange, protein transport, establishment of mitochondrial morphology and mitochondrial 
division, and inheritance of mitochondrial DNA23-27. However, because ER-mitochondria contact 
sites are dynamic structures with several co-localized multisubunit complexes, it has proven 
difficult to discriminate between direct and indirect ERMES functions. For example, the role of 
ERMES in PS transfer has been controversial, confounded by redundancy in lipid transport 
mechanisms between mitochondria and the rest of the cell23, 26, 32. 
 Bioinformatic and structural analyses also support the idea that ERMES plays a role in 
lipid trafficking. SMP (synaptotagmin-like, mitochondrial and lipid-binding protein) domains 
have been identified in Mdm12, Mdm34, and Mmm128 (Fig. 1B). SMP domain-containing 
proteins have been placed within the TULIP (tubular lipid-binding protein) superfamily of lipid / 
hydrophobic ligand-binding proteins, of which several protein structures are known29. In known 
TULIP structures with bound lipids, lipid acyl chains bind to the SMP channel lumen whereas 
lipid head groups lie outside the channel29. A recently published crystal structure confirmed the 
SMP domain of Mdm12 binds phospholipids in this manner30 (Fig. 2A).  
4	  
Biochemical analysis and EM reconstruction further suggest subunits Mdm12 and 
Mmm1 assemble into higher-order structure via SMP domain-mediated interactions, although 
the structural basis of this assembly remains unknown31 (Fig. 2C and D). Moreover, both 
Mdm12 and Mmm1 have been shown to be bona fide lipid-binding proteins with a preference for 
!
B
D
A
C
Figure 2. Putative Structure of Mdm12-Mmm1 Ternary Complex
A) Crystal structure of Mdm12 dimer from S. cerevisiae refined to 3.1 Å re-
solution. Disordered loop (74-113) and C-terminal residues (268-271) not shown.
Bound lipids are depicted by black stick models.
B) Putative Mdm12-Mmm1 assembly. Mmm1 (magenta/red) homodimer an-
chored to ER membrane shown binding Mdm12 (yellow) monomers via tail con-
tacts distal to Mdm12 dimer interface. 
C) Heterotetramer of Mdm12/Mmm1∆5 (Mmm1∆1-122) by EM random con-
ical tilt (RCT) reconstruction to 35 Å resolution. 
D) Heterotetramer of Mdm12/Mmm1∆1 (Mmm1∆1-161) by EM RCT recon-
struction with applied two-fold symmetry to 17 Å resolution. Envelope has
dimensions of ~210 x 45 x 35 Å. 
     
    Panels A/B adapted from Jeong H., et al. 2016. (ref. 30)
    Panels C/D adapted from AhYoung A.P., et al. 2015. (ref 31)
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PC, and to a lesser extent PI30,31. However, the lipid-binding properties and the assembly of 
ERMES subunits are still poorly understood. Additionally, no high-resolution structure of 
Mmm1, Mdm34, Mdm10, or any ERMES components in complex has been published.  
 
 
III. Assembly and Lipid-Binding of Mdm12 
Lipidomic and biochemical studies addressing Mdm12 lipid-binding specificity have 
demonstrated that Mdm12 capably binds several different species of phospholipids with 
appreciable affinity. Independent studies using quantitative mass spectrometry (MS) have shown 
that Mdm12 expressed in Escherichia coli co-purifies with predominantly PE and PG (~80% and 
~15% respectively)30,31. Displacement assays also demonstrate that PC, PE, PG, and to a lesser 
extent PI, all bind Mdm12 in vitro. Interestingly, MS analysis of Mdm12 incubated with 
liposomes of native yeast phospholipid composition revealed a two-fold enrichment of bound PC 
(~60%) relative to native composition (~27%), suggesting PC may be an endogenous ligand in 
vivo31. However, these in vitro biochemical studies stand in apparent contradiction to the finding 
that the ERMES complex specifically transports PS23,32. 
Recently published crystal structures of Mdm12 from S. cerevisiae revealed a dimer with 
an elongated tubular structure containing bound phospholipids30 (Fig. 2A). The SMP domain of 
the Mdm12 monomer closely resembles the topology of SMP domains in related proteins of 
known structure (Fig. 3). As in E-SYT2 the SMP domains in Mdm12 dimerize, whereas other 
members of the TULIP superfamily (e.g. BPI and CETP) contain two tandem SMP domains 
constituted by a single monomer33-35. The full-length of structure of Mdm12 details a unique β1 
domain swap that mediates self-assembly at the dimerization interface. Highly conserved β1-
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strands from each Mdm12 monomer form an intercalated hydrogen-bonding network between 
the β1- and β2-strands of the respective adjoining monomer (Fig 3A). This is a distinctive 
feature of Mdm12 not yet observed in any other SMP domain-containing proteins, suggesting 
that Mdm12 lipid binding may be governed by unique dynamics. For example, Mdm12 β1-strand 
mutants bind lipid with greater apparent affinity30. It is possible that Mdm12 monomer-dimer 
equilibrium serves some role in the dynamic organization of MAMs as it exists in vivo.  
 
A
B
Figure 3. Comparison of Mdm12 to 
known TULIP Superfamily Proteins.
A) Dimer interface of Mdm12 mediated 
by a β1-domain swap (inset) is unique 
among SMP domain-containing proteins. 
Sequence conservation of the β1-strand 
(residues 1-7) are shown for ten orthologs. 
B) Known TULIP proteins are structural-
ly similar to Mdm12 [(E-SYT2, RMSD: 
5.71), (CETP, RMSD: 4.47), (BPI, RMSD: 
4.26)]. The dimerization interface of 
E-SYT2 is characterized by highly 
conserved helices, in contrast to the β1 
domain swap in Mdm12. The two-fold 
symmetrical interface between the tandem 
SMP domains of CETP and BPI are both 
comprised of six-stranded central β-sheets. 
Figure adapted from Jeong H., et al. 2016 (ref. 30)
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Structural evidence also suggests Mdm12 preferentially binds phospholipids containing 
cationic functional groups. In particular, conserved acidic residues proximal to dimerization 
interface of Mdm12 contribute to a strong negative surface charge that may provide a structural 
basis for head-group selectivity (Fig. 4). Displacement assays performed with a surface charge 
mutant corroborated the structure-driven hypothesis. Of note, there was no electron density 
observed for the C-terminus (also proximal to the head-group of bound lipids) of any Mdm12 
monomer in the crystal structure, and whether it plays a dynamic role in lipid binding is 
unknown. Additionally the authors observed no electron density for non-conserved residues 74-
114. A crystal structure of ∆Mdm12 (∆74-114) demonstrated that the major features of full-
length Mdm12 are preserved without these residues. Yet despite no apparent sequence 
conservation, several Mdm12 orthologs contain a corresponding non-conserved sequence of 
variable length (Fig. 5). Although generality may not be drawn from the role of this region of 
Mdm12 from S. cerevisiae, this non-homologous region may contribute to unique plurality of 
Mdm12 function at membrane contact sites in different species.  
Figure 4. Structural Basis for Glycerophosphilipid Selectivity of Mdm12. Views of structural 
features suggesting Mdm12 may have preference for phospholipids containing positively 
charged functional groups in the headgroup region. A surface representation colored by electro-
static potential (left) shows negative charge density proximal to modeled PE head-group. The 
same view colored by sequence conservation (right) indicates negatively charged residues are 
highly conserved among Mdm12 orthologs.
Figure adapted from Jeong H., et al. 2016. (ref. 30)
C
onservation 
Low 
High 
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Figure 5. Sequence Conservation of Mdm12. Sequence alignment to Mdm12 
orthologs in fungi. Completely and highly conserved residues shown in red and 
yellow, respectively. Secondary structural elements are represented as follows: 
helices--yellow, strands--green, loops--solid line, disordered--dotted line.
Figure adapted from 
Jeong H., et al. 2016 (ref. 30)
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Materials and Methods 
I. Cloning and Protein Purification 
 cDNA encoding full-length Mdm12 WT from S. cerevisiae were each cloned into a 
pET28a vector containing an N-terminal His6-tag. Mdm12 ∆C92S was generated by site directed 
mutagenesis of the Mdm12 WT construct, and confirmed by sequencing. Constructs were 
transformed into E. coli BL21 (DE3) cells and grown at 37˚C to an OD600 of 0.7 before overnight 
induction with 1 mM IPTG at 18˚C. Cells were then harvested by ultracentrifugation, 
resuspended in lysis buffer (20 mM HEPES [pH 7.4], 100 mM NaCl) supplemented with 1 mM 
PMSF, and lysed by probe sonication at 4˚C. Mdm12 was purified at 4˚C using Ni-NTA 
chromatography, followed by gel filtration chromatography (Superdex 75 10/300 GL, GE 
Healthcare) and eluted in lysis buffer. Mdm12 WT ∆Ca2+ (calcium removed) was subject to 
dialysis against an EDTA-containing buffer (20 mM HEPES [pH 7.4], 100 mM NaCl, 5 mM 
EGTA) prior to gel filtration. Protein was concentrated by centrifugation and flash frozen using 
liquid nitrogen as needed. 
 
II. Analytical Ultracentrifugation (AUC) 
 Sedimentation velocity experiments were conducted at either 20˚C or 5˚C and 
centrifuged 40,000 RPM. Measurements were taken using an analytical ultracentrifuge 
(Beckman-Coulter XL-I) equipped with absorbance optics. Samples were first loaded into double 
sector cells fitted with quartz windows, equilibrated in the centrifuge for ~1 hour at the 
respective temperature, and then accelerated to the final rotor speed (40,000 RPM). Absorbance 
measurements at 280 nm were acquired at 4.5 minute intervals for ~9.5 hours. The experiment 
was performed at multiple concentrations for each experiment. Continuous sedimentation 
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coefficient distribution, c(s), analysis was performed using a resolution of 0.05S and maximum 
entropy regularization with a 95% confidence limit to determine the sedimentation coefficients  
for each species in the sample.
III. Liposome preparation and characterization.  
All lipids (POPC, POPE, TOCL, NBD-PE) were provided as chloroform stocks from 
Avanti Polar Lipids. Lipids were dried under a nitrogen stream for 20 min and lipids films were 
subsequently desiccated overnight. Lipids were hydrated in reaction buffer (20 mM HEPES [pH 
7.5], 100 mM NaCl) for 30 min, and extruded (≥13 times) manually using a mini-extruder at 
room temperature through a 0.1µm polycarbonate membrane (Avanti Polar Lipids, USA) to form 
large unilamellar vesicles (LUVs). The final total lipid concentration of the extruded LUVs was 
measured using an ammonium ferrothiocyanate colorimetric analysis37. Dynamic light scattering 
measurements were obtained from backscatter intensities measured at 25˚C using a Zetasizer 
Nano ZS (Malvern Instruments, Worcestershire, U.K.) as described below. The size and 
morphology of 100% NBD-PE LUVs was confirmed by transmission electron microscopy 
(TEM), also described below. 
 
IV. Native PAGE Analyses 
 Effect of reductant (DTT). Purified Mdm12 WT and Mdm12 ∆C92S (16.2 µM) in 
reaction buffer was mixed with increasing concentrations of DTT and incubated with an 
equimolar ratio of NBD-PE(18:1) (100% NBD-PE LUVs prepared as described in appendix 
A.II) at room temperature for 45 min. Reactions were resolved on a 12% acrylamide native gel 
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and Mdm12 was visualized by Coomassie stain. Fluorescence was visualized by FITC scans 
using a PharosFXPlus Gel Imager (Bio-Rad) and Image Lab 3.0 software.  
 Effect of calcium. Purified Mdm12 ∆Ca+2 and calcium-reintroduced Mdm12 ∆Ca+2 (5.8 
µM) were pre-incubated with reaction buffer and calcium-supplemented buffer (20 mM HEPES 
[pH 7.4], 100 mM NaCl, 500 µM CaCl2), respectively, for 5 min. Samples were then mixed with 
increasing concentraitons of DTT and incubated with an equimolar ratio of NBD-PE(18:1) 
(100% NBD-PE LUVs prepared as described in appendix A.II) at room temperature for 45 min. 
Reactions were resolved on a 12% acrylamide native gel and in-gel fluorescence was visualized 
using a PharosFXPlus Gel Imager (Bio-Rad) and Image Lab 3.0 software. 
 
V. Docking with Glide 
 Preparation of Mdm12. The crystal structure of full-length Mdm12 (PDB 5GYD) was 
prepared using the Protein Preparation Wizard workflow in Maestro (Schrödinger). Hydrogen 
atoms were added to the biological unit structure during preprocessing, however missing loops 
remained omitted. Heteroatom states were generated using Epik (pH: 7.0 ± 2.0). Hydrogen bond 
assignments were optimized and restrained 
minimization (OPLS3 Force Field) was performed to 
yield the final prepared structure. 
 Ligand library generation and preparation.  
A phospholipid library was manually curated for 
Mdm12 docking. SDF files were downloaded from 
the LIPID Metabolites and Pathways Strategy  
database (LIPID MAPS). 
TABLE I.  LIPID LIBRARY FOR GLIDE DOCKING 
Phospholipid	   Fatty Acid Composition PC	  (32:1)	   (14:0/18:2(11Z,14Z))	  	   (14:0/18:2(9Z,12Z))	  	   (14:1(9Z)/18:1(9Z))	  	   (16:1(9Z)/16:1(9Z))	  PE	  (34:2)	   (16:1(9Z)/18:1(9Z))	  
PG	  (34:1)	   (16:0/18:1(9Z))	  	   (18:1(9Z)/16:0)	  PI	  (32:1)	   (14:0/18:1(9Z))	  	   (14:1(9Z)/18:0)	  	   (16:0/16:1(9Z))	  
PS	  (34:1)	   (16:0/18:1(9Z))	  	   (16:1(9Z)/18:0)	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The previously identified30,31 predominant Mdm12-bound S. cerevisiae phospholipid species 
PC(32:2) and PG(34:1) were included, in addition to PE(34:2),  PI(32:1) and PS(34:1). Fatty acid 
compositions of each respective species naturally present in S. cerevisae were included in the 
library (Table 1)36. 3-dimensional models of library lipids were subsequently prepared using 
LigPrep (Schrödinger) with SDF-defined stereochemical contraints. Epik was used to generate 
ionization states (pH: 7.0 ± 2.0) and OPLS3 used for restrained minimization.	   
 Receptor grid generation. The receptor grid was generated for one monomer (PDB 
5GYD//B) of the Mdm12 homo-dimer automatically by identifying the co-crystallized ligand. 
Ser260 was defined as a rotatable group and the default van der Waals radius scaling factor (1.0) 
and partial charge cutoff (0.25) were kept and subject to OPLS3 force field. A second grid was 
generated with a headgroup NOE for subsequent constrained PC docking. 
 Glide Extra Precision (XP) ligand docking. XP flexible ligand docking was performed 
using Glide38 (Schrödinger). Default settings including ligand van der Waals scaling (0.80) and 
partial charge cutoff (0.15) were used. Post-docking minimization was performed on the ten best 
poses for each ligand and a maximum of three poses per ligand were reported. Per-residue 
interaction scores for residues within 12.0Å of the ligand were written to the report file.
 
VI. Dynamic Light Scattering (DLS) 
 Mdm12-mediated liposome remodeling. Purified Mdm12 WT (500 µL of 1 µM) was 
mixed with an equimolar amount of 100% NBD-PE LUVs (500 µL of 1 µM NBD-PE) in a 1.5 
mL microfuge tube at room temperature. At each recorded time point of the interaction the 
sample tube was inverted 5 times to ensure even mixing, and a 60 µL aliquot of sample was 
loaded into a quartz cuvette. The cuvette was washed between each time point sample. 
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Measurements were acquired at 25˚C using a ZetaSizer Nano S (Malvern Instruments, UK) with 
a 4-mW He-Ne laser (λ = 633 nm), and particle sizes were determined by back-scattering at 
173˚. Data analysis was performed using DTS Nano software (Malvern Instruments, UK).   
 
VI. Transmission Electron Microscopy (TEM) 
 LUVs of 100% NBD-PE (~0.9 mM) were plasma cleaned and imaged by negative 
staining (uranyl acetate), both alone and after brief incubation (~5 min) with Mdm12 WT (10 
µM). Images were collected at 18,500-150,000x on a Tecnai 12 G2 Spirit BioTWIN 
transmission electron microscope (FEI, Oregon, USA) with an acceleration voltage of 80.0 kV. 
 
VII. Fluoresence Titrations and Timecourse  
 Time course measurements. Fluorescence wavescans of NBD-PE (λex = 470 nm, λem = 
500-600 nm) were performed using a Fluorolog 3-22 spectrofluorometer (HORIBA Jobin-Yvon) 
equipped with a 450-W xenon lamp (λex = 470 nm), a photon-counting digital photomultiplier 
(λem = 500-600 nm), and double grating excitation and emission monochromators (5 nm 
bandpass; 5 nm bandpass). 250 µL reactions (20 nM Mdm12 WT; 0.4 µM NBD-PE) with DTT 
(4 mM) or without, were briefly mixed at room temperature. Samples were then transferred to 
quartz cuvettes (1 cm pathlength) and wavescans were measured as described above. Wavescans 
were recorded consecutively at each time point for the duration of the time course, until the 
fluorescence intensity reached a maximum (2-186 min). Samples were not mixed between 
consecutive measurements. The fluorescence intensity (cps) at the NBD emission maximum (λex 
= 530 nm) was plotted as a function of time, and fit using non-linear least-squares regression 
(Kaleidagraph, Synergy Software, PA). 
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VII. Stopped-flow Fluorescence 
Pre-steady-state kinetics experiments were performed with an SX-20 stopped-flow 
instrument (Applied Photophysics, UK). Samples were excited at 465 nm and emission was 
detected using a 500 nm long-pass cutoff filter. Mdm12 and NBD-PE LUVs were loaded into a 
1.0 mL syringes at double the final reaction concentration, respectively, and equal volumetric 
mixing ratio of Mdm12: NBD-PE was used. The final concentration of NBD-PE was constant in 
all experiments (1 µM) and the concentration of Mdm12 was titrated (0.025-2.5 µM). To test the 
effect of reductant on the kinetics of lipid-binding, Mdm12 WT and Mdm12 ∆Ca+2 were 
preincubated (~5 min) with 1 mM DTT before loading and initiating the lipid-binding reaction. 
For calcium reintroduced experiments, Mdm12 ∆Ca+2 was preincubated in reaction buffer 
containing 5 µM CaCl2 for ~5 min before samples were loaded and the lipid-binding reaction 
was intiated. All experiments were performed in reaction buffer. Measurements were collected 
for 10, 100, and 1000s reactions and data were analyzed using SX Pro-Data Viewer (Applied 
Photophysics, UK). Triplicate fluorescent transients from a single experiment were averaged and 
fit to multiexponential curves, in which an additional exponential term was added to account for 
photobleaching. The rate of this fixed additional term was determined by NBD-PE—reaction 
buffer equal-mixing control experiments. 
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Results 
I. Oligomeric State of Mdm12 
 A construct of full-length Mdm12 containing an N-terminal 6XHis-tag (His-Mdm12) was 
expressed in E. coli and purified as described above. As also observed by Jeong, et al., 2016, the 
TEV cleavage site was inaccessible to protease and only small amounts of TEV-cleaved Mdm12 
could be formed by proteolysis (not shown). This suggests that the fold of the N-terminal region 
of Mdm12 may occlude the TEV cleavage site. The elution profile of His-Mdm12 shows two 
distinct species corresponding approximately to the MW of the Mdm12 monomer and dimer  
(Fig. 6). Native PAGE analysis of Mdm12-containing fractions indicates that the distribution of 
oligomers is dynamic, as either peak fraction redistributes into a dimer/monomer mixture 
immediately upon elution. A large fraction of Mdm12 appears in earlier fractions suggesting 
either that there is significant aggregation or that Mdm12 also forms higher-order oligomers.  
 
AUC suggests that the dimeric species of Mdm12 is the most abundant oligomer (~85%, 
S20,w ≈ 4S) both at low temperature (5˚C) and at room temperature (20˚C) (Fig. 7). However at 
room temperature, Mdm12 exists in monomer/dimer equilibrium whereas a dimer/tetramer 
mixture is observed at low temperature (Fig. 7A). Moreover, both the monomer and tetramer 
Figure 6. Mdm12 exists as 
multiple oligomeric states. 
GFC run at 4˚C on an S75 
column (A) and at room 
temperature on an S200 
column (B) separates Mdm12 
into monomer/dimer fractions. 
Mdm12-containing fractions 
run on native PAGE indicate 
this monomer-dimer equilibri-
um is dynamic as all peak frac-
tions can redistribute into a 
mixture of monomer (band 1) 
and dimer (band 2).
A B
Figure 7. Temperature affects the oligomeric state of Mdm12. (A) Continuous sedimentation coef-
ficient distribution c(s) of Mdm12 at different temperatures as measured by AUC. The molecular 
weight corresponding to the main peak (s ~ 3.9 Svedbergs) is consistent with that of an Mdm12 dimer. 
Analysis of c(s) distribution shows no concentration dependence on the distribution of different MW 
species at low temperature (B) or at room temperature (A). Mdm12 exists as a mixture of two species, 
the monomer and dimer at room temperature, and the dimer and tetramer at low temperature.
A B C
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comprise 15% of the total sample at high and low temperature, respectively, and remain in 
constant proportion to the total amount of dimer (85%) (Table 2).  
 
 
 
 
The association state of Mdm12 can be disrupted by the introduction of reductant DTT, 
suggesting that Mdm12 forms disulfide-mediated oligomers (Fig. 8A). Mutagenesis experiments 
suggest cysteine 92 (Mdm12 ∆C92S) in particular is critical in mediating the formation of the 
Mdm12 dimer. Mdm12 ∆C92S exists as primarily a monomer even in the absence of DTT, and 
moreover when pre-incubated with DTT Mdm12 ∆C92S exhibits no change in the distribution of 
monomer and dimer equilibrium (Fig. 8B). In gel FITC scans showing NBD-PE bound to 
Mdm12 illustrate that both dimer and monomer can capably bind lipids (Fig. 8A/B, NBD-PE). 
Self-association of Mdm12 has been previously reported30,31, however previous results indicate 
that His-tagged Mdm12 forms only the monomeric species. Moreover our finding that Mdm12 
Figure 6. Mdm12 exists as 
multiple oligomeric states. 
GFC run at 4˚C on an S75 
column (A) and at room 
temperature on an S200 
column (B) separates Mdm12 
into monomer/dimer fractions. 
Mdm12-containing fractions 
run on native PAGE indicate 
this monomer-dimer equilibri-
um is dynamic as all peak frac-
tions can redistribute into a 
mixture of monomer (band 1) 
and dimer (band 2).
A B
Figure 7. Temperature affects the oligomeric state of Mdm12. (A) Continuous sedimentation coef-
ficient distribution c(s) of Mdm12 at different temperatures as measured by AUC. The molecular 
weight corresponding to the main peak (s ~ 3.9 Svedbergs) is consistent with that of an Mdm12 dimer. 
Analysis of c(s) distribution shows no concentration dependence on the distribution of different MW 
species at low temperature (B) or at room temperature (C). Mdm12 exists as a mixture of two species, 
the monomer and dimer at room temperature, and the dimer and tetramer at low temperature.
A B C
TABLE 2. ANALYTICAL ULTRACENTRIFUGATION PARAMETERS Sample	   MW(1) (kDa) s(1)	  (Svedbergs)	   s(2)	  (Svedbergs)	   [m(2)] [m(1)]! 	   RMS	  error	  (A280)	  	  20˚C	   	  32.2	   	  2.44	   	  3.83	   	  2.76†	   	  0.013	  	  4˚C	   	  61.6	   	  4.06	   	  5.78	   	  0.073‡ 	  0.0136	  
† Corresponds to an average weight percentage of 15% for the monomer and 85% for the dimer. 
‡ Corresponds to an average weight percentage of 87% for the dimer and 13% for the tetramer. 	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dimerization is disulfide-mediated stands in contrast to structural evidence showing that Mdm12 
forms a homodimer mediated by swapping of the highly conserved β1-strand. 
In the reducing cellular environment it is possible that Mdm12 does not form disulfide-mediated 
oligomers as it exists in the ERMES complex. On the other hand, there is no structural 
information currently available for the large disordered loop containing residue C92 (residues 
74-114), and given the finding that C92 is important for reversible dimerization it is possible that 
it may play some role in Mdm12 assembly in vivo.   
 
Interestingly, calcium may potentiate the effect of DTT on the oligomeric state of 
Mdm12. FITC scans of preliminary native PAGE gels show that the change in fluorescence 
intensity of the lipid-bound species of Mdm12 dialyzed in EGTA (Mdm12 ∆Ca+2) may be less 
responsive to DTT than Mdm12 ∆Ca+2 pre-incubated with calcium ions (Fig. 8C). However, 
FITC scans of both gels show minimal response to treatment with DTT. Also, FITC scans alone 
are not sufficient to measure possible changes to the oligomeric state of Mdm12. Changes in 
band intensity may only reflect changes in the ability of Mdm12 to bind lipids, and not 
Figure 8. DTT and Ca+affect the oligomeric state of Mdm12. Mdm12 WT (A) and Mdm12 ∆C92S (B) 
were incubated with NBD-PE LUVs at increasing DTT concentrations. At high DTT concentrations, the 
higher MW species (dimer ~66 kDa) is shifted partially to the lower MW species (monomer ~33 kDa) as 
imaged by coomassie staining. FITC gel images indicate both MW species have bound NBD-PE. Mdm12 ∆
C92S exists predominantly as the lower MW species even at low DTT concentration. (C) Ca2+ potentiates 
Mdm12 WT sensitivity to DTT. FITC scans of preliminary gels indicate that the higher MW species of  
Mdm12 ∆Ca2+ is less responsive to reduction by DTT than Mdm12 ∆Ca2+ with reintroduced calcium.
A B C
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changes in oligomeric state. In subsequent experiments the gels must also be stained to resolve 
protein bands to ensure that the intensity of the bands measured by FITC also reflect relative 
amounts of Mdm12. 
 
II. Phospholipid Docking of Mdm12 in silico 
 Glide was used to dock a library of phospholipids into the binding site of Mdm12. The 
library of candidate glycerophospholipid ligands was manually curated based on the 
aforementioned MS findings of Mdm12-bound lipid species30,31 (Table 1). Fatty acid 
composition was selected to mimic acyl chains found naturally in S. cerevisiae36. Mdm12 (PDB 
5GYD) was prepared using the default Protein Preparation Workflow (Schrödinger) and a grid 
was generated for the lipid-binding site of one monomer of the homo-dimer assembly, defined 
by identifying the co-crystallized ligand. For the second round of docking specifically with PC, 
another grid was defined with a NOE constraint to bias docking into generating a pose with the 
tertiary amine of PC in proximity to the acidic residues hypothesized to play a role in forming 
favorable interactions with choline headgroup. XP flexible ligand docking was then performed 
using Glide with default settings. Nearly all generate poses were in the posture observed as in the 
co-crystallized ligand, wherein the acyl chains lie within the SMP lumen and the headgroup is 
solvent-exposed (Fig. 9A).  
Interestingly, the hypothesized in vivo ligand (PC) generated the least favorable poses of 
all species docked (Fig. 9B). Moreover, those generated showed an abnormal inverted pose in 
which one acyl chain docked within the SMP lumen and the other occupied the expected 
headgroup region, while the choline headgroup formed favorable contacts with the dimerization 
interface. A second round of docking was performed in which the aforementioned NOE 
constraints were defined to bias poses such that the choline headgroup was proximal to the 
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highly conserved, positively charged residues of interest. Only two poses could be generated in 
the second round of docking, and only with one of three PC species, PC(14:1(9Z)/18:1(9Z)). One 
of these poses had a highly favorable GlideScore (-11.126) while the other pose was relatively 
unfavorable (-5.039). It is likely that the lipid-binding site of the Mdm12 is dynamic in vivo, and 
this particular crystallized posture may not be representative of the PC-bound state. Likely a PC-
bound state would require a larger width of the lateral seam of the SMP domain proximal to the 
dimerization interface. Of note, an Mdm12 monomer from this crystal structure alone can easily 
accommodate a choline headgroup. This is, if repeated with only the monomer PC would likely 
generate a large number of favorable poses.  
PI(14:0/18:1(9Z))
XP GScore: -12.859
PE(16:1(9z)/18:1(9Z))
XP GScore: -12.306
PS(16:1(9Z)/18:0)
XP GScore: -10.059
PG(16:0/18:1(9Z))
XP GScore: -11.243
PC(14:1(9Z)/18:1(9Z))
XP GScore: -11.126
BA C
D E F
Figure 9. Top poses of Mdm12-docked phospholipd ligands. (A) The overall pose of cocrystal-
lized lipid ligand (PE) with the acyl chains (olive) facing the SMP lumen, and the ethanolamine 
headgroup (blue) exposed to solvent. The glycerol moeity is shown in gray. Residue-specific 
interactions (H-bond:black, coulombic interaction:yellow) between the headgroup of the docked 
phospholipid and the binding site of Mdm12 are shown for (B) phosphatidylcholine (PC), (C) 
phosphatidylethanolamine (PE), (D) phosphatidylglycerol (PG), (E) phosphatidylinositol (PI), and  
(F) phosphatidylserine (PS).
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PI (14:0/18:1(9Z)) generated the two best poses of all docked ligands (Fig. 9E). Although 
the inositol headgroup is large and non-ionized, it forms extensive polar contacts with the main 
chain atoms of conserved residues W261, I262, and N263. Of note, the previous MS data 
indicates that Mdm12 is highly enriched in bound PI species relative to normal cellular 
concentrations in S. cerevisiae. Docking of PG and PS species also generated a large number of 
poses with favorable XP GlideScores (Fig. 9D & F). Similarly, the conserved residues of interest 
participating in favorable contacts with inositol headgroups also participated in extensive 
favorable contacts with both PG and PS headgroups. However, no ligands other than PE, and PC 
in the second round of docking, formed favorable contacts with E255, the highly conserved 
residue previously hypothesized to specifically play a critical role in headgroup selectivity. In 
fact, PI, PG, and PS all formed significant unfavorable interactions with E255. Perhaps E255 
may play a role in headgroup specificity by a mechanism of negative headgroup selectivity 
(forming unfavorable interactions with particular headgroups) rather than by positive selectivity 
as previously hypothesized. 
Docking of the cognate ligand PE generated the most favorable docking scores on 
average. Notably, the protein sample used to determine the Mdm12 crystal structure was purified 
from E. coli, in which PE composes ~80% of the total lipid composition. The co-crystallized 
lipid of the structure used for docking was modeled to be a completely saturated species of PE, a 
species not commonly found in vivo. Moreover, MS analyses of lipids bound to Mdm12 purified 
from E. coli have shown that ~80% of bound lipid is indeed PE. Therefore, the binding site used 
for Glide docking represents a conformation biased for favorable PE docking.  
Headgroup specificity, however, is not the primary determinant of favorable docking. 
Rather, interactions between the SMP lumen and the acyl chain compose the vast majority of 
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favorable binding interactions (Fig. 10). In all cases lipophillic contacts between the acyl chains 
and hydrophobic residues in the SMP lumen are significantly more abundant than electrostatic 
interactions between lipid head-groups and the conserved proximal residues (Fig. 10B & C). 
However, poses that had fewer favorable headgroup contacts also had fewer favorable lipophilic 
interactions and inversely, those with many favorable headgroup contacts also had a large 
number of favorable lipophilic interactions. Hence, for any given lipid it cannot be said whether 
the headgroup specifically was the cause for the generation of the favorable pose. Additional 
docking studies in which the acyl chain is kept constant and in a fixed conformation can be 
performed to more specifically investigate only the effects of particular lipid headgroups on 
docking score.  
Taken together, multiple lipid ligands generate highly favorable poses within the 
crystallized binding site and it is likely that Mdm12 binds multiple lipid species as it exists in the 
ERMES complex in vivo. Moreover, this study suggests that headgroup specificity plays a 
minimal energetic role in Mdm12 lipid binding.  
 
A B C
Figure 10. XP Glide docking of glycerophospholipids. (A) Box plot of XP GlideScore by phospholipid 
shows that multiple lipids dock with highly favorable docking scores except for PC. PE docks with the 
most favorable score on average and PI docking generated the most favorable pose overall. The XP Glide-
Score depends on both electrostatic (B) and lipophillic vdW (C) interactions between Mdm12 and the 
docked ligand. 
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III. Mdm12 Remodels Synthetic Bilayers 
 The effect of Mdm12 binding on overall liposome size and morphology was assessed by 
time course DLS experiments and transmission electron microscopy. Mdm12 induced large-scale 
morphological changes including fusion, tubulation, tethering, and solubilization of 100% NBD-
PE liposomes (Fig. 11). Prior to interaction with Mdm12, NBD-PE LUVs were monodisperse 
with an approximate hydrodynamic radius (DH) of 100nm as measured by DLS, and exhibited 
normal morphology (Fig. 11A/E). DLS also showed that purified Mdm12 alone is solution was 
also monodisperse (DH ~1-10 nm) prior to interaction with NBD-PE LUVs.  
 Upon Mdm12-binding TEM images illustrate dramatic changes in the overall 
morphology of the LUVs. Moreover, time course DLS experiments suggested that Mdm12 lipid- 
Figure 11. Mdm12 induces vesicle fusion and bilayer reorganization. (A/E) Stable large unilamellar 
vesicles (LUVs) composed of 100% NBD-PE can be formed in isolation (DH ~100 nm).  (B) Upon intial (5 
min) interaction with Mdm12 NBD-PE LUVs form aggregates. (C) Between 14-63 min interaction the 
predominant species measured by DLS and visualized by volume PSD is approximately the size of the 
Mdm12 in isolation (DH ~1-10 nm). (D) Aggregates again begin to form at 71 min and continue to form until 
reaction equilibrium at 90 min. LUVs and Mdm12 were incubated at equimolar concentrations. (F-H) Rep-
resentative TEM images of the different liposome morphologies induced upon Mdm12 interaction with 
LUVs are shown.
A B C D
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binding is a complex multi-step reaction, and may be broadly separated into three distinct phases. 
The first phase occurs upon initial interaction (5 min) at which point liposomes begin to form 
large aggregates (Fig. 11C/F). A second phase is characterized by a sudden decrease of the 
average particle size (DH ~1-10nm) in the sample as measured by volume distribution. 
Interestingly, this is the same size as Mdm12 alone in solution. This second phase is prolonged, 
and the average particle size in solution remains constant for ~60 min at room temperature (Fig. 
11E/G). A third and final apparent phase shows a second phase of aggregation, in which the 
average particle size increases to form three distinct populations (DH ~50nm, ~100-200nm, and 
>10µm) (Fig. 11G). It cannot be said with certainty whether this size distribution of aggregate is 
distinct from that formed in the initial aggregation phase. 
 
IV. Kinetics of Mdm12 Lipid Binding 
A fluorescence-based approach was used to investigate Mdm12 lipid-binding at finer 
kinetic resolution. Stopped-flow was used to perform rapid mixing experiments in which Mdm12 
and LUVs of 100% NBD-PE were mixed at equal volumes, where the relief of NBD self-
quenching was interpreted as a readout for Mdm12—lipid interaction. Stopped-flow results 
corroborated the findings from DLS experiments, also indicating that Mdm12 interacts with 
liposomes via a complex multiphasic reaction consisting of at least three different kinetic phases 
(Fig. 12). First, there is an initial rapid phase (~10 ms) and that accounts for only a small 
increase (<5%) in the overall fluorescence signal (Fig. 12A). This is followed by a longer (~1-40 
sec) secondary phase, which contributes a much larger proportion of the total fluorescence 
signal(~50%) (Fig. 12B). The reaction never saturated even at the maximum programmable time 
interval on the stopped-flow apparatus (1000 sec). Rather, the reaction enters a third phase (~50 
sec) that appears linear at the timescales measured by stopped-flow, and also contributes
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significantly (~50%) to the overall Mdm12-induced fluorescence change (Fig. 12C). 
Importantly, the rate and magnitude of the fluorescence response is dependent on the 
concentration of Mdm12 added, suggesting that the combined overall reaction is governed by at 
minimum first order kinetics with respect to the Mdm12 concentration (Fig. 12D). However, the 
fluorescence output from NBD dequenching is a combination of multiple potential reactions (e.g. 
lipid phase change, Mdm12 lipid-binding). This ambiguity greatly confounds data analysis and 
makes it difficult to distinguish and characterize each kinetic phase individually. 
Stopped-flow measurements also showed that both DTT and calcium affect the kinetics 
of Mdm12 lipid binding. Pre-incubation of Mdm12 with 1 mM DTT increases the rate and 
overall magnitude of Mdm12 lipid binding (Fig. 13A). Although our finding that Mdm12 
dimerization is disulfide-mediated stands in contrast to the β1-strand swap observed in the 
[Mdm12]:[Lipid]
1:20
1:10
1:5
1:2.5
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Figure 12. Kinetics of Mdm12 Lipid Binding. Three distinct phases of 
Mdm12 interacting with liposomes are apparent. (A) The first phase is 
rapid (~10 ms) and contributes minimally to the overall fluorescence 
increase (<5%). (B) The second phase occurs subsequently (1-40 s) and 
is followed by (C) a third linear phase, which is the longest in duration. 
(D) The rates and amplitude of all three phases are dependent on the 
concentration of Mdm12.
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crystal structure, biochemical studies accompanying the structure similarly observed that Mdm12 
binds lipids with greater affinity as a monomer rather than a dimer.  
Similarly, the removal of calcium (Mdm12 ∆Ca+2) also increases the overall reaction rate 
and fluorescence response (Fig. 13B). Upon the reintroduction of calcium (5 µM) to Mdm12 
∆Ca+2, the reaction rate and fluorescence signal are restored to wild type levels. Interestingly, 
Mdm12 ∆Ca+2 also treated with DTT exhibits a combinatorial effect on reaction kinetics. That is, 
the presence of reductant in addition to the absence of calcium increases the overall rate and 
amplitude of the fluorescence response greater than either treatment alone (Fig. 13C). Control 
experiments mixing DTT or calcium with NBD-PE LUVs alone confirm that the fluorescence 
response is attributable to modulated Mdm12 activity. Calcium is a tightly regulated and potent 
secondary messenger at MAMs, and this is the first direct biochemical evidence that suggests it 
may affect MAM function via ERMES. 
 
WT 
+DTT 
  LUVs 
+DTT 
WT 
+Ca+2 
Ca+2 
Ca+2 
WT 
Ca+2 
+DTT 
+DTT 
  LUVs 
+Ca2+ 
Figure 13. Calcium and DTT affect the kinetics of Mdm12 lipid binding. (A) Mdm12 WT and liposomes 
of 100% NBD-PE were rapid-mixed at equimolar concentration. In the presence of reductant DTT, the rate 
of reaction and the amplitude of the overall fluorescence signal was amplified. DTT alone had no effect on 
the dequenching of NBD fluorescence. (B) When calcium is removed by dialysis with EGTA-containing 
buffer (∆Ca+2), the overall fluorescence signal and the rate of reaction also increase. When calcium is rein-
troduced the kinetics of interaction are restored to that of Mdm12 WT before dialysis. Calcium alone has no 
effect on dequenching of NBD fluoresence. (C) The absence of calcium and presence of reductant have a 
combinatorial effect on the kinetics of interaction.
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Because Mdm12 lipid-binding does not reach equilibrium at time intervals accessible by 
stopped-flow, another NBD dequenching-based method was used to observe the reaction until 
saturation. A spectrofluorometer was used to collect consecutive wavescans (500-600 nm) of 
Mdm12 lipid-binding reactions until signal saturation (Fig. 14). Binding of Mdm12 WT with 
NBD-PE LUVs saturated ~60 min (Fig. 14B), corresponding to the same time at which the 
beginning of the second aggregation phase was observed in DLS time course experiments. Time 
course measurements of Mdm12 treated with 1 mM DTT corroborated stopped-flow results, and 
relieved NBD self-quenching at a faster rate and induced a larger response than Mdm12 alone 
(Fig. 14A/C). Moreover, DTT-treated Mdm12 lipid-binding reactions took longer to saturate 
(~120 min vs. ~60 min). Additionally, the emission maximum of NBD in the DTT-treated 
reaction is further blue-shifted (λem= 527 nm vs. λem= 535 nm) (Fig. 14D) indicating NBD on 
average is in a lower dialectric environment. Although not conclusive this could suggest that 
more total lipid is bound at equilibrium to DTT-treated Mdm12, which would support the 
previous findings that the Mdm12 monomer binds lipids more readily than the dimer. 
A B
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Figure 14. Mdm12 Lipid-Binding Reaction 
Time Course. Lipid binding reactions were 
performed (20 nM Mdm12; 0.4 µM 
NBD-PE) for both Mdm12 WT (B) and 
Mdm12 WT preincubated with DTT before 
lipid-binding (A) and consecutive wavescans 
were recorded until saturation. Mdm12 prein-
cubated with DTT relieved self-quenching of 
NBD significantly faster and induced a much 
larger response (2.4x) than untreated Mdm12 
(C). The reaction also proceeded for 186 min 
until reaching full saturation (not shown), 
whereas lipid-binding saturated after ~60 min 
with untreated Mdm12. In both experiments 
NBD-PE LUVs alone measured a λem= 557 
nm, and a blue shift was observed upon addi-
tion of Mdm12. However, the emission 
maxima differed between DTT (λem= 
527 nm) and untreated Mdm12 (λem= 535 
nm) lipid-binding (D). 
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Discussion 
Because ER-mitochondria contact sites are major conduits of lipid trafficking 
independent of the endomembrane system, illumination of the molecular basis of ERMES-
mediated phospholipid transport is poised to uncover novel concepts in membrane biology. 
Membrane contact sites are ubiquitous yet also enigmatic. Understanding how the SMP domain-
containing subunits of ERMES assemble to recognize, extract, and transport phospholipids could 
possibly characterize a general mechanism for lipid transport at membrane contact sites in 
general. To this end, this study sought to investigate the assembly state and lipid binding 
properties of ERMES subunit Mdm12 in isolation.  
Our finding that Mdm12 exists primarily as a dimer in dynamic equilibrium corroborates 
previous findings30,31,41. However, in this study we found Mdm12 oligomerization to be 
primarily disulfide-mediated and facilitated largely by C92 disulfide bond formation. Of note, 
our biochemical analyses of Mdm12 association state were performed using a full-length N-
terminal His-tagged construct, before structural information was available. Crystal structures 
show that Mdm12 forms dimers mediated by contacts between conserved β1-strands. 
Interestingly, a recent structure of Mdm12 demonstrates that β1-mediated dimerization is 
promiscuous, in that β1-strands can mediate self-association by either strand swapping30 or 
asymmetrically with only one strand engaged at the dimer interface (Fig. 15A/C)41. Additionally, 
all structures to date show a ‘non-crystallographic’ dimer mediated by large crystal contact 
surfaces that exceed the buried surface area of the bona fide dimer interface (Fig. 15B). The 
unresolved disordered loop containing C92 is proximal to this interface, and because our 
construct contains an N-terminal His-tag that likely occludes β1-strand interaction, the dimer 
observed in this work is likely distinct from that previously investigated. 
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Moreover, all purification and biochemical studies of Mdm12 to date have been 
performed under highly reducing conditions (2.8 mM31, 41, and 5 mM30 BME) and AhYoung et 
al. (2015) even performed mutagenesis of C92 to improve sample homogeneity for 
crystallization41. Although this disordered region is variable, little is known about the local redox 
environment at membrane contact sites and it is possible that disulfide-mediated dimerization has 
physiological function. 
 Although it is widely assumed that ERMES mediates non-vesicular lipid transport, this 
study is the first to investigate Mdm12—bilayer interaction and demonstrate the effect of an 
ERMES subunit on overall bilayer morphology. It is clear from the experimental findings 
presented above that Mdm12 significantly disrupts the integrity of lipid bilayers composed of 
NBD-PE. It is important to note that when derivatized with an NBD moiety conjugated to the 
headgroup PE no longer exhibits polymorphic phase behavior42-44. Rather NBD-PE is 
characterized as a lamellar lipid, hence its ability to form stable bilayers averse to high curvature. 
Although a molecular interpretation of the mechanism of Mdm12—bilayer interaction is still 
lacking, the data presented in this study clearly demonstrate the ability of Mdm12 to disrupt lipid 
Figure 15. Dimerization interface of 
Mdm12. (A) β1-strand-swapped dimer 
previously shown from Jeong et al. 
(2016). (B) Non-swapped/non-crystallo-
graphic dimer corresponding to an 
‘anti-parallel’ arrangement along helix 
H2 proximal to C92. This large contact 
interface may directly involve C92 and is 
observed in every Mdm12 structure to 
date. (C) An asymmetric pseudo 
‘head-to-head’ dimer involving only the 
β1-strand from monomer A. 
Figure adapted from AhYoung et al. (2017) 
A B
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bilayers and induce significant polymorphism. Real-time stopped-flow and DLS measurements 
also show that reaction progression follows a defined progression of Mdm12-mediated bilayer 
changes. Taken together we propose a coarse working model for the mechanism of Mdm12 
action on lipid bilayers (Fig. 16).   
Figure 16. Proposed Model for Mdm12—Bilayer Interaction. In isolation Mdm12 significantly disrupts 
synthetic bilayers (NBD-PE). These changes occur in distinct phases at different rates. Representative TEM 
images showing putative Mdm12-induced morphologies corresponding to the propposed model. (1) 
Mdm12 must first interact with the exterior surface of liposomes, however, the specific interactions that 
mediate association are unknown. (2) A small amount of tethering is apparent and aggregation accompanies 
the destabilization of the bilayer. (3) This induces bilayer fusion, and (4) subsequent lysis or solubilization. 
The reaction continues to equilibrium until again aggregate is formed, which may or may not distict from 
aggregates formed in previous phases. 
Schematic adapted from R.I. Abu-Ghazaleh et al. 1992
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Mdm12 first binds the exterior leaflet of bilayers likely by a combination of electrostatic and 
hydrophobic interactions, however the energetic basis of this interaction is unknown. Binding 
induces liposome clustering and features of membrane tethering, and tubulation is also observed. 
Bilayer destabilization induces aggregation and fusion of clustered liposomes. As shown using 
DLS average particle size decreases to the size of Mdm12 alone in solution, possibly indicating 
membrane solubilization. Although there is no direct evidence of the ability of Mdm12 to breach 
the lipid bilayer, from TEM images we speculate that the integrity of liposome 
compartmentalization is compromised. Large granular aggregates are visible in TEM images and 
could be representative of solubilized lipid—Mdm12 aggregates.  Of additional note, stopped-
flow measurements showed that calcium modulates the lipid-binding of Mdm12. Because ER-
mitochondria contact sites are major conduits for calcium exchange, a deeper understanding of 
this effect is of particular interest.  
 These findings stand in apparent contrast to the notion that ERMES facilitates monomeric 
lipid transport independent of fusion and large-scale membrane morphological changes. 
Preliminary results have indicated that other SMP domain-containing proteins facilitate lipid 
transport without concurrent fusion4. Mdm12 also bridges the connection between juxtaposed 
membranes via interaction with Mmm1 and Mdm34. Thus, Mdm12 is assumed to be a 
transducer of lipid transport and have limited direct contact with the bilayer. It is very likely that 
Mdm12 interacts differently in physiological context. Regardless, these results provide a starting 
point to address the major question of how SMP domain-containing proteins are able to extract 
and deposit lipids into adjacent bilayers at membrane contact sites. 
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Appendix A 
Analysis of SS-31 Lipid Binding Kinetics 
I. Abstract 
The SS-31 peptide is a synthetic tetrapeptide containing an alternating cationic-aromatic 
motif that represents a first-in-class therapeutic which restores compromised mitochondrial 
bioenergetics (Fig. A1A). By modulating the ultrastructure of the mitochondrial inner membrane 
(IMM) SS-31 is thought to restore oxidative phosphorylation, leading to clinical improvements 
in a diverse set of complex diseases. However, the biophysical mode of SS-31 action remains 
uncharacterized. Despite bearing a +3 net charge at physiological pH, SS-31 is readily taken up 
by all tested cell types to date and targeted specifically to the IMM46. Intriguingly, there is no 
apparent receptor or transporter-mediated requirement for uptake or localization, and the 
distribution of SS-31 within mitochondria was found to be membrane potential independent47. 
A B
Figure A1. SS-31 specifically binds TOCL. 
A) The chemical structures of SS-31 and 
fluorescent labeled [ald]SS-31.
B) Proposed model illustrating binding 
mode of SS-31 to TOCL.
C) Chemical structures of CL variants 
TOCL, dCL, and the CL remodeling 
intermediate MLCL, which accumulates in 
the mitochondria of BTHS patients.
C
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Using a combination of nuclear magnetic resonance (NMR), Rayleigh scattering, and 
fluorescence-based approaches, it was later revealed that SS-31 selectively binds to cardiolipin 
(CL), a unique phospholipid which has two phosphate headgroups connected by a single glycerol 
moiety, and is found principally in the IMM48. From these data it was proposed that SS-31 and 
tetraoleoyl cardiolipin (TOCL) interact at a 1:1 molar ratio, in which electrostatic interactions 
between the two cationic residues of one SS-31 molecule and the two phosphate head-groups of 
TOCL align the aromatic residues for hydrophobic interaction with the acyl chain region (Fig. 
A1B). This study explores the potential use of SS-31 as a therapeutic for Barth Syndrome 
(BTHS), a multisystemic disorder caused by mutation of the gene encoding tafazzin, the 
transacylase responsible for the remodeling of acyl chains during TOCL biosynthesis. BTHS 
patients show decreased levels of CL and an accumulation of the biosynthetic intermediate 
monolysocardiolipin (MLCL) (Fig. A1C). The following kinetic analysis of the interactions 
between SS-31 and CL variant-containing bilayers points to the potential use of SS-31 to treat 
BTHS, and gives key mechanistic insights into the mode of SS-31 binding. 
 
II. Materials and Methods 
Steady-state fluorescence. Stock solution of [ald]SS-31 (250 µM) was prepared by re-
suspension of  lyophilized peptide in reaction buffer (20 mM HEPES [pH 7.5], 100 mM NaCl). 
CL-containing LUV stock solutions (250 µM) were prepared as described above. Samples were 
mixed at each respective concentration LUVs and incubated for 20 min then transferred to 250 
µL quartz sample cuvettes (4x4-mm). Measurements were made using a Spex Fluorolog 3-22 
spectrofluorometer (HORIBA Jobin-Yvon) with double-grating excitation/emission 
monochrometers (Ex: λ = 360 nm, Em: λ = 400-600 nm, 2-nm bandpass). ∆Emission at 461 nm
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was used to define specific binding, and the data were fit to the Hill-equation (Eqn. 1) to 
extrapolate binding parameters. 
𝜃 = [L]𝑛𝐾𝑑+[L]𝑛        (Equation 1) 
Stopped-flow fluorescence. Pre-steady-state kinetics experiments were performed with 
an SX-20 instrument (Applied Photophysics, UK). Samples were excited at 360 nm and emission 
was detected using a 400 nm long-pass cutoff filter. Peptide and LUVs were loaded into a 1.0 
mL syringes at double the final reaction concentration, respectively, and equal volumetric mixing 
ratio of [ald]SS-31: LUVs was used. The final concentration of [ald]SS-31 was constant in all 
experiments (1 µM) and the concentration of CL-variant LUVs was titrated. All experiments 
were performed in reaction buffer (20 mM HEPES [pH 7.5], 100 mM NaCl). Data were analyzed 
using SX Pro-Data Viewer (Applied Photophysics, UK). Triplicate fluorescent transients from a 
single experiment were averaged and fit to multiexponential curves, in which an additional 
exponential term was added to account for photobleaching. The rate of this fixed additional term 
was determined by peptide : reaction buffer equal-mixing control experiments.  
 
III. Results 
Biphasic membrane binding by [ald]SS-31 
 The association between [ald]SS-31 and CL-containing bilayers was found to be a 
biphasic process characterized by two distinct kinetic phases, an initial rapid phase followed by a 
subsequent slow phase (Fig. A2). The rate of the fast phase (k1) linearly increased with 
accessible lipid concentration upon titration with liposomes containing TOCL, dCL, or MLCL. 
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Moreover, the rate of the fast phase contributed significantly more to the overal fluorescence 
increase (~60-95%). The forward rate of the rapid association phase (k +1) was approximately 
3.60 µM-1sec-1 for each CL-variant, whereas the reverse rate of the phase (k -1) differed between  
species. The differences in the affinity constants (KD) that were extrapolated from pre steady-
state kinetic measurements are hence, most largely attributable to variations in the reverse rate 
constant k -1. The slow rate, however, was not dependent on the lipid concentration and remained 
approximately constant at ~0.4 s-1 (not shown) for all CL species, indicating this is either a zero-
order process or a first-order process subsequent to the first concentration-dependent reaction. 
Steady-state measurements also showed close agreement with pre-steady state results, and 
indicate that [ald]SS-31 binds with low micro-molar affinity to bilayers containing TOCL, dCL, 
and MLCL (Fig. A3).  
TOCL dCL MLCL
A B C
D E F
Figure A2. Kinetics of SS-31 binding to CL-containing bilayers. (A-C) Representative stopped-flow 
fluorescence transients of [ald]SS-31 (1 µM) added to liposomes containing 50 mol% of CL variants at the 
indicated lipid concentration. Binding of [ald]SS-31 to liposomes is biphasic. (D-F) Association (kon) and 
dissociation (koff) rate constants determined by pseudo first-order approximation for the first phase of 
[ald]SS-31 binding to CL variants. Insets show the first 30 ms binding transients identifying the first phase.
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IV. Discussion 
 Taken together, these results can be 
represented by a minimal model for the 
kinetic mechanism of [ald]SS-31 bilayer 
association:	   
 
where the kinetic parameters shown are 
those measured for TOCL-containing 
bilayers, and the peptide and liposomes are 
represented by 𝑃  and 𝐿 , respectively. P:L 
represents the product of the initial rapid 
reaction, and P:L* represents the product of the subsequent slow reaction phase. The fast phase 
likely correspond to an initial phase bilayer interaction mediated by electrostatic and 
hydrophobic interactions between the basic and aromatic residues of SS-31. In contrast the 
slower phase may correspond to the alignment of peptides within the bilayer via peptide—
peptide interactions, or represent alterations in bilayer properties such as interfacial packing.  
 Of particular note SS-31 binds MLCL-containing bilayers with similar affinity to TOCL-
containing bilayers, supporting the notion that SS-31 may well be effective in targeting the IMM 
of mitochondria in Barth Syndrome patients, and possibly in ameliorating the characteristic 
bioenergetics deficiencies. Moreover, the kinetics of [ald]SS-31 binding to CL-containing 
bilayers are generally the same for TOCL, dCL, and MLCL, in which there is rapid phase 
dependent on lipid concentration followed by a subsequent slow phase that does not depend on 
A B
C D
Figure A3. Equilibrium binding of SS-31 to CL-containing bilayers.
(A) Emission spectra of [ald]SS-31 (1 µM) incubated to equilibrium (20 
min) with liposomes containing 50 mol% TOCL of 100 mol% POPC (B). 
(C) Saturation binding curves of [ald]SS-31 with increasing concentrations 
of liposomes containing 50 mol% of the respective CL variants shown. 
Curves were fit to Hill expansions of Langmuir binding isotherms, and 
fitted parameters were reported with the standard deviation and as the mean 
of triplicate experiments (D).
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lipid concentration. Although k -1 differed between CL-variants, the other measured parameters   
k -1 and k 2 were consistently similar. Interestingly the Hill coefficients for TOCL and MLCL 
binding were greater than that measured for dCL, and this may represent subtle differences in 
head-group dependent SS-31—CL interactions. Changes in head-group geometry and chemistry 
may also affect interfacial packing and the alignment of peptides already bound to the bilayers.  
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